The screening mammography paradox: better when found, perhaps better not to find
- PMID: 18506172
- PMCID: PMC2410106
- DOI: 10.1038/sj.bjc.6604349
The screening mammography paradox: better when found, perhaps better not to find
Comment on
-
Screen-detected vs symptomatic breast cancer: is improved survival due to stage migration alone?Br J Cancer. 2008 Jun 3;98(11):1741-4. doi: 10.1038/sj.bjc.6604368. Epub 2008 May 27. Br J Cancer. 2008. PMID: 18506175 Free PMC article.
Similar articles
-
Do tumors detected by mammography screening have a favorable prognosis?JAMA. 2004 Sep 1;292(9):1062-3. doi: 10.1001/jama.292.9.1062. JAMA. 2004. PMID: 15339899 No abstract available.
-
Risk for distant recurrence of breast cancer detected by mammography screening or other methods.JAMA. 2004 Sep 1;292(9):1064-73. doi: 10.1001/jama.292.9.1064. JAMA. 2004. PMID: 15339900
-
The value of mammography in estimating the prognosis for patients with breast cancer.Recent Results Cancer Res. 1984;90:173-8. doi: 10.1007/978-3-642-82031-1_25. Recent Results Cancer Res. 1984. PMID: 6701375 No abstract available.
-
Screening for breast cancer.Surg Oncol Clin N Am. 2005 Oct;14(4):671-97. doi: 10.1016/j.soc.2005.06.001. Surg Oncol Clin N Am. 2005. PMID: 16226686 Review.
-
[Diseases of the female breast: screening, mammography, ultrasound].Ther Umsch. 1993 May;50(5):323-33. Ther Umsch. 1993. PMID: 8378888 Review. German.
Cited by
-
Simulation Modeling to Extend Clinical Trials of Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Early Breast Cancer.JNCI Cancer Spectr. 2019 Aug 10;3(4):pkz062. doi: 10.1093/jncics/pkz062. eCollection 2019 Dec. JNCI Cancer Spectr. 2019. PMID: 32337487 Free PMC article.
-
Cost-effectiveness of targeted versus tailored interventions to promote mammography screening among women military veterans in the United States.Eval Program Plann. 2011 May;34(2):97-104. doi: 10.1016/j.evalprogplan.2010.07.003. Epub 2010 Aug 6. Eval Program Plann. 2011. PMID: 20810168 Free PMC article. Clinical Trial.
-
Breast cancer screening: controversy of impact.Breast. 2013 Aug;22 Suppl 2(0 2):S73-6. doi: 10.1016/j.breast.2013.07.013. Breast. 2013. PMID: 24074796 Free PMC article. Review.
-
Impact of mammographic screening on the detection of good and poor prognosis breast cancers.Breast Cancer Res Treat. 2011 Dec;130(3):725-34. doi: 10.1007/s10549-011-1748-z. Epub 2011 Sep 4. Breast Cancer Res Treat. 2011. PMID: 21892702 Free PMC article. Review.
-
Lead-time bias in esophageal cancer screening in high-risk areas in China.Chin J Cancer Res. 2020 Aug;32(4):467-475. doi: 10.21147/j.issn.1000-9604.2020.04.04. Chin J Cancer Res. 2020. PMID: 32963459 Free PMC article.
References
-
- Bazell R (1998) Her-2: The Making of Herceptin, a Revolutionary Treatment for Breast Cancer. New York: Random House
-
- Berry DA, Cirrincione C, Henderson IC, Citron ML, Budman DR, Goldstein LJ, Martino S, Perez EA, Muss HB, Norton L, Hudis C, Winer EP (2006a) Estrogen-receptor status and outcomes of modern chemotherapy for patients with node-positive breast cancer. JAMA 295: 1658–1667, Erratum in: JAMA 295: 2356, doi: 10.1001/jama.295.14.1658 - PMC - PubMed
-
- Berry DA, Cronin KA, Plevritis SK, Fryback DG, Clarke L, Zelen M, Mandelblatt JS, Yakovlev AY, Habbema JDF, Feuer EJ, Cancer Intervention and Surveillance Modeling Network (CISNET) Collaborators (2005) Effect of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med 353: 1784–1792 - PubMed
-
- Berry DA, Inoue L, Shen Y, Venier J, Cohen D, Bondy M, Theriault R, Munsell MF (2006b) Modeling the impact of treatment and screening on US breast cancer mortality: a Bayesian approach. J Natl Cancer Inst Monogr 36: 30–36 - PubMed
-
- Fryback DG, Stout NK, Rosenberg MA, Trentham-Dietz A, Kuruchittham V, Remington PL (2006) The wisconsin breast cancer epidemiology simulation model. J Natl Cancer Inst Monogr 36: 37–47 - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical